Sweden-based medical device company Pharmacolog (STO:PHLOG) announced on Thursday that it has signed an agreement with B. Braun Portugal, a medical technology company, to distribute DrugLog and PrepLog with associated services in Portugal.
Pharmacolog said that the DrugLog system enables hospital pharmacies to implement additional quality control by verifying the identity and concentration of compounded injectable medications. Adding that it is ideal for chemotherapy and compounded medications.
The agreement with B. Braun Portugal aligns with Pharmacolog's strategy to broaden its distribution network. The extension of the agreement is a result of a successful collaboration with B. Braun in Spain.
Lars Gusch, CEO of Pharmacolog, commented that the agreement reinforces the long-term collaboration between the two companies.
FDA Grants Breakthrough Device Designation to Tempus' HLA-LOH Companion Diagnostic Test
Nephron Pharmaceutical names new chief procurement officer
Belluscura secures 6,500 DISCOV-R orders, demonstrates strong market demand
Anteris Technologies' DurAVR THV proves successful in second valve-in-valve procedure
Rokit Healthcare receives certification under CEMDR for 'Dr Invivo AI Regen Platform'
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
Paindrainer AB's innovative pain management app secures FDA Class 1 approval
Anteris Technologies Launches ADR program for US investors
Pharming initiates Phase III trial in Japan for leniolisib in APDS treatment
Pharming enrols first patient in Phase III leniolisib clinical trial in Japan
Complement Therapeutics names new chief medical officer
Belluscura expands respiratory offerings with McKesson distribution agreement